News for Zealand Pharma A/S (ZLDPF)

Zealand Pharma A/S (OTCPK:ZLDPF) Q4 2024 Earnings Conference Call February 20, 2025 8:00 AM ETCompany ParticipantsAnna Krassowska - VP, IRAdam Steensberg -...

**media[545266]**

**media[540154]**

Move over, Novo Nordisk and Eli Lilly. Why Pfizer and Roche look like top choices for investors.

Denmark stocks higher at close of trade; OMX Copenhagen 20 up 2.51%

Move over, Novo Nordisk and Eli Lilly. Why Pfizer and Roche look like top choices for investors.

Denmark stocks lower at close of trade; OMX Copenhagen 20 down 2.17%

Denmark stocks lower at close of trade; OMX Copenhagen 20 down 1.51%

**media[500638]**

Denmark stocks higher at close of trade; OMX Copenhagen 20 up 3.74%

Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.

Denmark stocks higher at close of trade; OMX Copenhagen 20 up 3.74%

Denmark stocks lower at close of trade; OMX Copenhagen 20 down 13.21%

**media[497232]**

Denmark stocks lower at close of trade; OMX Copenhagen 20 down 2.82%

Denmark stocks higher at close of trade; OMX Copenhagen 20 up 1.93%

Denmark stocks higher at close of trade; OMX Copenhagen 20 up 1.10%

The FDA has approved 43 novel drugs so far this year (January-November), compared to 52 during the same period last year. As we step into the final month of the year, let's take a look at the biotech companies whose drugs are under regulatory review in the U.

Denmark stocks higher at close of trade; OMX Copenhagen 20 up 1.92%